Explore evidence

10.57 %The prevalence of hepatitis B virus infection in the central regions of Burkina Faso was 10.57%.

Burkina Fasohépatite Bpublished 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

21.11 %Among HIV-positive women, Candida albicans colonization was identified in 21.11%.

Burkina FasoCandida albicans colonizationpublished 2011Journal of infection in developing countrieseurope_pmcdocument of 12 observationsDOI 10.3855/jidc.950

62,315 casesIn 2025, a total of 62,315 cases (12,909 confirmed; 156 probable; 49,250 suspected) and 139 deaths (CFR: 0.22%) of dengue fever have been reported from 11 AU MS: Burkina Faso, Cabo Verde, Comoros, Guinea, Kenya, Mali, Mauritania, Mauritius, Nigeria, Senegal, and Sudan.

Burkina Faso · Guinée · Kenya · Mali · Mauritanie · Nigeria · Sénégal · Soudandengueobserved 2025Africa CDCdocument of 6 observations

50 %During the rainy season, around 50% of patients had a new malaria episode by Day 28.

Burkina Fasopaludismepublished 2017Annals of parasitologyeurope_pmcdocument of 4 observations

24.5 %Among SARS-CoV-2 cases in Burkina Faso as of 21 June 2020, 24.5% of deaths occurred in the 44–59 age group.

Burkina FasoCOVID-19observed 21 June 2020HAL · Unilimdocument of 97 observations

14.3 titerAt day 180, the PfCSP-specific geometric mean titer (GMT) was 14.3 in the ProC6C-AlOH group.

Burkina Fasopaludismeobserved D180HAL · Unilimdocument of 39 observations

3.9 %The prevalence of Epstein Barr Virus subtype 1 (EBV-1) was 3.9% (9/238) in HIV-positive patients in Burkina Faso.

Burkina Fasovirus Epstein-Barrpublished 2017Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 9 observations

High prevalence of insecticide resistance was detected in Vallée du Kou (VK) to pyrethroids, DDT, and dieldrin.

Burkina Fasopaludismepublished 2013Geneeurope_pmcdocument of 6 observations

5.28 mosquitoes_per_house_per_nightIn Gaoua, the mean nightly Anopheles density dropped from 5.28 mosquitoes/house/night in year 1 to 1.43 in year 2 and rebounded to 2.75 in year 3.

Burkina FasopaludismeHAL · Unilimdocument of 87 observations

9.41 %The prevalence of hepatitis B virus infection in the general population of Burkina Faso was 9.41% after adjustment.

Burkina Fasohépatite Bpublished 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

10 %The prevalence of congenital malaria by qPCR increased to 10% among newborns from mothers infected at delivery in the Nanoro health district, Burkina Faso.

Burkina Fasopaludismepublished 2017Scientific reportseurope_pmcdocument of 2 observationsDOI 10.1038/s41598-017-02173-6

5 signalsA review of the manufacturer package leaflets, an online Multi-Drug Symptom/Interaction Checker (DoubleCheckMD) and further by therapeutic area experts reduced the number of signals to five.

Burkina Fasopaludismepublished 2014PloS oneeurope_pmcdocument of 4 observationsDOI 10.1371/journal.pone.0096388

9.3 %Before treatment, the prevalence of triple DHFR mutations was 9.3% among patients without recurrent parasitemia.

Burkina Fasoparasitemiapublished 2007The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.2007.76.608

11 %L'intervention a entraîné une augmentation moyenne de la couverture de CPN4+ de 11 % au cours de la phase active de l'intervention au Burkina Faso.

Burkina FasogrossesseHAL · Unilimdocument of 302 observations

Dengue fever has been reemerging in Burkina Faso with annual outbreaks since 2013.

Burkina Fasodengueobserved 2013published 2020Tropical medicine and infectious diseaseeurope_pmcdocument of 5 observations

86.56 %In the town of Koudougou, 86.56% of respondents reported a low risk of malaria contamination when living more than 500m from waste.

Burkina FasopaludismeHAL · Unilimdocument of 110 observations

4.85 minutesAnopheles gambiae stopped swarming 4 minutes and 51 seconds earlier than Anopheles coluzzii.

Burkina Fasopaludismepublished 2013Parasites & vectorseurope_pmcdocument of 7 observationsDOI 10.1186/1756-3305-6-275

60 %Culture detected bacterial causes of purulent meningitis in 60% (56/93) of tested patients.

Burkina Fasoméningite bactérienneobserved 2009–2010published 2013Medecine et sante tropicaleseurope_pmcdocument of 9 observations

34.8 %Vaccine efficacy of RTS,S/AS01 against severe malaria in the combined age categories was 34.8% in the per-protocol population during an average follow-up of 11 months.

Burkina Fasopaludismepublished 2011The New England journal of medicineeurope_pmcdocument of 7 observationsDOI 10.1056/nejmoa1102287

The first two cases of SARS-CoV-2 in Burkina Faso were identified on 9 March 2020.

Burkina FasoCOVID-19observed 9 March 2020HAL · Unilimdocument of 97 observations

98.5 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 98.5% showed a 10-fold increase in anti-CSP IgG antibody titres post-2017 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2017HAL · Unilimdocument of 105 observations

70 %In two populations from Burkina Faso (2007–2008), hemoglobin S heterozygosity (AS) was associated with a 70% reduction in harboring Plasmodium falciparum parasitemia compared to hemoglobin AA.

Burkina Fasopaludismeobserved 2007-2008published 2015The Journal of infectious diseaseseurope_pmcdocument of 3 observations

11 casParmi les échantillons positifs à la qPCR pour le virus de l'hépatite B, 11 ont testé positif pour les anticorps anti-HBc IgM, suggérant des infections aiguës.

Burkina Fasohépatite BHAL · Unilimdocument of 26 observations

2.8 %In Nanoro, Burkina Faso, the VAGKGS haplotype was present in 2.8% of samples in 2020.

Burkina Fasopaludismeobserved 2020published 2024Scientific reportsPubMeddocument of 4 observations

12 %Fever was caused by pneumonia in 37 cases (12%) among 306 non-malaria endemic travellers who consulted the French embassy’s Centre Médico-Social in Ouagadougou for fever.

Burkina FasopneumonieHAL · Unilimdocument of 83 observations